Is there level I evidence for complementary and alternative medicine (CAM) in oncology? An analysis of Cochrane Reviews

2012 ◽  
Author(s):  
Jutta Huebner ◽  
Karsten Muenstedt ◽  
Ralph Muecke ◽  
Oliver Micke
Keyword(s):  
Alternative Medicine ◽  
Complementary And Alternative Medicine ◽  
Cochrane Reviews ◽  
Level I ◽  
Complementary And Alternative

scholarly journals Resistance to Antibiotics and Antifungal Medicinal Products: Can Complementary and Alternative Medicine Help Solve the Problem in Common Infection Diseases? The Introduction of a Dutch Research Consortium

2015 ◽  
Vol 2015 ◽  
pp. 1-6 ◽  
Author(s):  
Esther T. Kok ◽  
Miek C. Jong ◽  
Barbara Gravendeel ◽  
Willem B. Van Leeuwen ◽  
Erik W. Baars
Keyword(s):  
Antibiotic Resistance ◽  
Alternative Medicine ◽  
Complementary And Alternative Medicine ◽  
Therapeutic Interventions ◽  
Vaginal Candidiasis ◽  
Sufficient Evidence ◽  
Clinical Effects ◽  
Positive Effects ◽  
Cochrane Reviews ◽  
Complementary And Alternative

The increase of antibiotic resistance worldwide, rising numbers of deaths and costs associated with this, and the fact that hardly any new antimicrobial drugs have been developed during the last decade have increased the interest in Complementary and Alternative Medicine (CAM) therapeutic interventions, if proven safe and effective. Observational studies on clinical CAM practices demonstrate positive effects of treatment of infections with CAM therapies (clinical effects, patient satisfaction) in combination with small percentages of antibiotics prescription. However, Cochrane reviews and other studies demonstrate that in most instances the quality of clinical trials on CAM treatment of infections is currently too low to provide sufficient evidence. Therefore a Dutch consortium on (in vitro and clinical) scientific research on CAM and antibiotic resistance has been formed. The aim and objective of the consortium is to establish an enduring partnership and to develop expertise to further develop and investigate safe and effective CAM treatments for infectious diseases of humans (and animals). A first ongoing project on the development of safe and effective biobased CAM antimycotics in women with (recurrent) vaginal candidiasis infection is introduced.

Sign in / Sign up

Export Citation Format

Share Document